EPS Becomes First Domestic CRO to Obtain 'myMedidata eCOA Accreditation'
NQ Score
82/100
N1 Content Completeness
9
AI Summary (NQ-processed)
EPS has obtained certification to build Medidata's eCOA solutions, potentially reducing trial setup time to as little as two months.
AI Analysis
Frequently Asked Questions
- Q: What is the 'myMedidata eCOA Accreditation' qualification?
- A: It is a certification from Medidata's official accreditation program to acquire specialized knowledge for building and managing eCOA solutions in-house.
- Q: What are the benefits for EPS in obtaining this qualification?
- A: It enables an in-house setup for eCOA, speeding up trial configuration (from 4 months to as short as 2 months) and optimizing costs.
- Q: What are the features of Medidata's eCOA solution?
- A: Through the patient portal 'myMedidata', it allows for the verification and signing of consent forms, diary entries, and online consultations with doctors.
- Q: How will this partnership impact clinical trials in Japan?
- A: It will enable optimized support for the Japanese market and faster trial setup, improving the efficiency of clinical trials and patient experience.
- Q: What kind of company is Medidata?
- A: Medidata is a leading provider of clinical trial solutions for the life sciences industry and is a subsidiary of Dassault Systèmes.